Stay updated on Pembrolizumab as AML Post-Remission Treatment Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a software release. There are no visible changes to the study content or page functionality beyond the metadata.
    Difference
    0.1%
    Check dated 2026-07-25T17:14:48.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    A new revision tag v3.6.3 replaced v3.6.2 on the page. This indicates a small update to the page template or content management.
    Difference
    0.1%
    Check dated 2026-07-04T13:26:55.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.0 to v3.6.2, indicating a minor backend/UI update. This change does not alter the study details or their presentation to users.
    Difference
    0.1%
    Check dated 2026-06-27T05:51:29.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page now indicates no participants are being sought and adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment label formatting and changes the release note from Revision: v3.5.5 to Revision: v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T00:39:38.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    Revision updated to v3.5.5, indicating a software version update for the page. This change does not modify study details or other user-facing content.
    Difference
    0.1%
    Check dated 2026-06-05T16:26:00.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    The page has updated its revision number from v3.5.3 to v3.5.4, indicating a minor site update. The update does not alter the displayed study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-05-15T05:22:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab as AML Post-Remission Treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page.